InvestorsHub Logo
Followers 14
Posts 603
Boards Moderated 0
Alias Born 12/27/2017

Re: farrell90 post# 369261

Saturday, 08/07/2021 12:08:58 AM

Saturday, August 07, 2021 12:08:58 AM

Post# of 403455
Not sure I see this as a possibility that could be entertained w/o a major partnership that's vertical and could manufacture + distribute.

UNLESS Leo has a DOD contract or similar.

Still... I don't see it happening.

P3 + partnership.

I'd prefer to see it licensed, or the company acquired honestly.

Remdesivir was given an EUA at the interim report of its Phase 3 study. That's my best guess for Brilacin.

It could be sooner if the Phase 2 shows outstanding results, acing all the primary and secondary outcomes with absolute safety.

The other factor is the status of the pandemic. If the Delta virus outbreak continues to accelerate or if vaccine resistant or more deadly variants appear, Brilacidin could be pushed up to the drug of choice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News